Stay updated on Aducanumab in Early Alzheimer's Clinical Trial

Sign up to get notified when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Aducanumab in Early Alzheimer's Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Publication note updated to say publications are automatically filled from PubMed, and the page revision was updated to v3.3.2 (replacing v3.2.0).
    Difference
    0.0%
    Check dated 2025-11-25T10:46:55.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The notice about government funding and potential data currency issues has been removed from the page; it previously stated that information may not be up to date and pointed users to opm.gov for status updates.
    Difference
    0.1%
    Check dated 2025-11-18T06:56:59.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Taiwan site entry updated from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704'.
    Difference
    0.0%
    Check dated 2025-11-11T02:38:35.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    No substantive changes to core study information were detected; the Study Details content and the list of locations appear unchanged between the two screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T20:58:10.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    2%
    Check dated 2025-10-06T05:23:51.000Z thumbnail image
  9. Check
    82 days ago
    Change Detected
    Summary
    Page now shows Revision: v3.1.0 and removes multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the prior content, indicating a reorganization or narrowing of topics with an updated version.
    Difference
    0.3%
    Check dated 2025-09-29T03:00:31.000Z thumbnail image

Stay in the know with updates to Aducanumab in Early Alzheimer's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.